ISSN: 1389-2010

Journal Home

Journal Guideline

Current Pharmaceutical Biotechnology Q2 Unclaimed

Bentham Science Publishers B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Pharmaceutical Biotechnology is a journal indexed in SJR in Biotechnology and Pharmaceutical Science with an H index of 97. It has an SJR impact factor of 0,492 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,492.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Pharmaceutical Science (Q2) Biotechnology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,492

SJR Impact factor

97

H Index

145

Total Docs (Last Year)

488

Total Docs (3 years)

13902

Total Refs

1310

Total Cites (3 years)

468

Citable Docs (3 years)

2.51

Cites/Doc (2 years)

95.88

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

BioChip Journal Q2
Biotechnology and Bioengineering Q2
World Journal of Microbiology and Biotechnology Q2
IEEE/ACM Transactions on Computational Biology and Bioinformatics Q2
Human gene therapy methods Q2

Compare this journals

Aims and Scope

Best articles by citations

Pharmacology and Clinical Effect of Platonin, a Cyanine Photosensitizing Dye: Potential Molecular Targets

Molecular Mechanisms of Several Novel Dipeptides with Angiotensin-Iconverting Enzyme Inhibitory Activity from In-silico Screening of Silkworm Pupae Protein

MATra - Magnet Assisted Transfection: Combining Nanotechnology and Magnetic Forces to Improve Intracellular Delivery of Nucleic Acids

Update on the Use of Biologics in Lupus

Update on the Use of Biologics in Vasculitides

Cytokines in Candidiasis and Aspergillosis

Biologics in Polymyositis and Dermatomyositis-Associated Interstitial Lung Disease

Biotherapy for Autoimmune Liver Diseases

Development and Characterization of Amphotericin B Nanosuspensions for Oral Administration Through a Simple Top-Down Method

Biologics in Systemic Sclerosis

Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1

Effect of Powdered Activated Carbon as Advanced Step in Wastewater Treatments on Antibiotic Resistant Microorganisms

SHOW MORE ARTICLES

Maternal Hair and Neonatal Meconium to Assess Gestational Consumption and Prenatal Exposure to Drugs of Abuse and Psychoactive Drugs

Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Incorporating Fatty Acid-Modified Polyethylenimine

Editorial (Thematic Issue: Oligonucleotide Delivery System)

Immune Responses to Therapeutic Proteins in Humans - Clinical Significance, Assessment and Prediction

Emerging Peptide Therapeutics for Inflammatory Diseases

Plasma Rich in Growth Factors Enhances Wound Healing and Protects from Photo-oxidative Stress in Dermal Fibroblasts and 3D Skin Models

Nanobiotechnology-based Drug Delivery in Brain Targeting

Editorial (Thematic Issue: Therapies Targeting Oxidative Stress for Human Diseases: Where Are We Now?)

Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients

Quantification of Methamphetamine <<Shabu>> in Biological Matrices to Detect Prenatal Exposure: A Case Report and a Literature Review

Downregulation of TdT Expression through Splicing Modulation by Antisense Peptide Nucleic Acid (PNA)

Anti-CD20 Antibody in Primary Sjogren's Syndrome Management